Source brief: InfluenceAsia is linking to and indexing this publicly available Medical story for editorial review. The full article should be read at the original publisher.
Original source title
A hidden weakness in deadly cancers could lead to powerful new treatments
Source-provided summary
A UCLA study has identified a hidden Achilles' heel in aggressive small cell cancers that have resisted new treatments for decades. Scientists found that tumors lacking the RB gene become critically dependent on the protein E2F3 for survival. Blocking E2F3 shut down tumor growth in laboratory models, and existing FDA-approved drugs may be able to exploit this vulnerability. The discovery could pave the way for faster development of more effective therapies.
Read the original report
ScienceDaily Health original article
Source and disclaimer
Source: This draft references publicly available reporting from ScienceDaily Health. InfluenceAsia does not claim ownership of the original publisher's article text, images, reporting, trademarks or other protected material.
Legal disclaimer: This page is an editorial intake draft for review, attribution and linking. It is provided for general information only and should not be treated as financial, investment, legal, tax, medical or professional advice. Editors should verify rights, names, dates, figures, quotations, claims, image licenses and source context before publication. Do not publish full third-party article text unless InfluenceAsia has the necessary rights or permission.
